Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
AstraZeneca
Baxter
UBS
Cipla
Cerilliant
Harvard Business School
Moodys
Johnson and Johnson

Generated: September 19, 2018

DrugPatentWatch Database Preview

Us Worldmeds Llc Company Profile

« Back to Dashboard

What is the competitive landscape for US WORLDMEDS LLC, and what generic alternatives to US WORLDMEDS LLC drugs are available?

US WORLDMEDS LLC has four approved drugs.

There are three US patents protecting US WORLDMEDS LLC drugs.

Summary for Us Worldmeds Llc
US Patents:3
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Us Worldmeds Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Worldmeds Llc XADAGO safinamide mesylate TABLET;ORAL 207145-002 Mar 21, 2017 RX Yes Yes 8,278,485 ➤ Sign Up Y ➤ Sign Up
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up
Us Worldmeds Llc ZELNORM tegaserod maleate TABLET;ORAL 021200-002 Jul 24, 2002 DISCN No No ➤ Sign Up ➤ Sign Up
Us Worldmeds Llc XADAGO safinamide mesylate TABLET;ORAL 207145-002 Mar 21, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Us Worldmeds Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Worldmeds Llc ZELNORM tegaserod maleate TABLET;ORAL 021200-001 Jul 24, 2002 5,510,353 ➤ Sign Up
Us Worldmeds Llc ZELNORM tegaserod maleate TABLET;ORAL 021200-002 Jul 24, 2002 5,510,353 ➤ Sign Up
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 3,935,267 ➤ Sign Up
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 3,935,267 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents for Us Worldmeds Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,901,176 Methods for treatment of Parkinson's disease ➤ Sign Up
9,492,410 Methods for treatment of Parkinson's disease ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Us Worldmeds Llc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015 00042 Denmark ➤ Sign Up PRODUCT NAME: KOMBINATION AF SAFINAMID OG LEVOPODA/PDI; REG. NO/DATE: EU/1/14/984/001-010 20150224
/2015 Austria ➤ Sign Up PRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
2015 00042 Denmark ➤ Sign Up PRODUCT NAME: KOMBINATION AF SAFINAMID, HERUNDER SAFINAMID METHANSULFONAT, OG LEVODOPA/PDI; REG. NO/DATE: EU/1/14/984/001-010 20150226
0505322/01 Switzerland ➤ Sign Up PRODUCT NAME: TEGASEROD; REGISTRATION NO/DATE:IKS 55689 20011030
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Queensland Health
Teva
Dow
McKinsey
McKesson
US Army
Cipla
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.